Literature DB >> 31128968

The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement.

Matthew R Cooperberg1, Peter R Carroll2, Marc A Dall'Era3, Benjamin J Davies4, John W Davis5, Scott E Eggener6, Felix Y Feng7, Daniel W Lin8, Todd M Morgan9, Alicia K Morgans10, Daniel E Spratt11, Samir S Taneja12, David F Penson13.   

Abstract

We convened a multidisciplinary expert panel to make recommendations on current utility and future research needs for post-diagnosis prostate cancer biomarkers. The San Francisco Consensus Statement reflects on the rapid recent progress achieved, and the substantial work still ahead. Published by Elsevier B.V.

Entities:  

Year:  2019        PMID： 31128968     DOI： 10.1016/j.eururo.2019.05.013

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


  8 in total

1.  Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer.

Authors:  Massimo Lazzeri; Vittorio Fasulo; Giovanni Lughezzani; Alessio Benetti; Giulia Soldà; Rosanna Asselta; Ilaria De Simone; Marco Paciotti; Pier Paolo Avolio; Roberto Contieri; Cesare Saitta; Alberto Saita; Rodolfo Hurle; Giorgio Guazzoni; Nicolò Maria Buffi; Paolo Casale
Journal:  Front Oncol       Date:  2022-09-06       Impact factor: 5.738

Review 2.  How should radiologists incorporate non-imaging prostate cancer biomarkers into daily practice?

Authors:  Pawel Rajwa; Jamil Syed; Michael S Leapman
Journal:  Abdom Radiol (NY)       Date:  2020-12

Review 3.  Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes.

Authors:  Stefano Salciccia; Anna Laura Capriotti; Aldo Laganà; Stefano Fais; Mariantonia Logozzi; Ettore De Berardinis; Gian Maria Busetto; Giovanni Battista Di Pierro; Gian Piero Ricciuti; Francesco Del Giudice; Alessandro Sciarra; Peter R Carroll; Matthew R Cooperberg; Beatrice Sciarra; Martina Maggi
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

Review 4.  Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer.

Authors:  Konrad Sopyllo; Andrew M Erickson; Tuomas Mirtti
Journal:  Cancers (Basel)       Date:  2021-02-05       Impact factor: 6.639

5.  SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study.

Authors:  Martina Maggi; Francesco Del Giudice; Ugo G Falagario; Andrea Cocci; Giorgio Ivan Russo; Marina Di Mauro; Giuseppe Salvatore Sepe; Fabio Galasso; Rosario Leonardi; Gabriele Iacona; Peter R Carroll; Matthew R Cooperberg; Angelo Porreca; Matteo Ferro; Giuseppe Lucarelli; Daniela Terracciano; Luigi Cormio; Giuseppe Carrieri; Ettore De Berardinis; Alessandro Sciarra; Gian Maria Busetto
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

Review 6.  From Cancer Epidemiology to Policy and Practice: the Role of a Comprehensive Cancer Center.

Authors:  Robert A Hiatt; Amanda Sibley; Brinda Venkatesh; Joyce Cheng; Niharika Dixit; Rena Fox; Pamela Ling; Tung Nguyen; Debora Oh; Nynikka R Palmer; Rena J Pasick; Michael B Potter; Ma Somsouk; Roberto Ariel Vargas; Maya Vijayaraghavan; Alan Ashworth
Journal:  Curr Epidemiol Rep       Date:  2022-03-21

7.  Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical Prostatectomy.

Authors:  Adam B Weiner; Farzana A Faisal; Elai Davicioni; R Jeffrey Karnes; Donald J Vander Griend; Tamara L Lotan; Edward M Schaeffer
Journal:  Eur Urol Oncol       Date:  2020-06-12

Review 8.  Data-driven translational prostate cancer research: from biomarker discovery to clinical decision.

Authors:  Yuxin Lin; Xiaojun Zhao; Zhijun Miao; Zhixin Ling; Xuedong Wei; Jinxian Pu; Jianquan Hou; Bairong Shen
Journal:  J Transl Med       Date:  2020-03-07       Impact factor: 5.531
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.